Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2295.13	-682.30	28.49
Graham Fair Price	1.41	21.17	20.87
PEG	132.05	4.20	-1.81
Price/Book	-1.69	2.30	2.34
Price/Cash Flow	-36.33	41.53	65.23
Prices/Earnings	-4.69	15.01	15.75
Price/Sales	1.30	13.53	13.36
Price/FCF	-36.33	41.53	65.23
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.49	1.01	1.00
Operating Margin	-68.85	0.31	-1.00
ROA	7.66	< 0.005	< 0.005
ROE	0.04	0.04	3.15
ROIC	-0.07	0.02	-67.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.14	4.78	-97.11
Dividends QOQ	< 0.005	0.05	699.32
EBIT QOQ	-4.33	1.30	-69.93
EPS QOQ	-0.09	0.04	-58.93
FCF QOQ	-0.18	0.54	210.40
Revenue QOQ	0.30	-0.03	-90.19
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.50	0.46	-7.46
Quick Ratio	1.14	1.10	-3.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.85	22.81	-0.15
Cash	95.97	85.57	-10.84
Capex	-0.12	-0.09	29.20
Free Cash Flow	0.82	1.26	54.18
Revenue	4.00	3.87	-3.10
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.29	0.23	-21.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.91	-56.20	6050.49
Naive Interpretation	Member

06 - Financial Health · Bad

Rating